July 31, 2026
A value European equity fund seeking long-term growth.
Is this fund right for you?
- You want your money to grow over a longer term.
- You want to invest in companies located or active in Western and Eastern Europe and whose shares are principally traded on European stock exchanges.
- You're comfortable with a moderate level of risk.
RISK RATING
How is the fund invested? (as of July 31, 2026)
| Name | Percent |
|---|---|
| International Equity | 95.8 |
| Cash and Equivalents | 2.2 |
| US Equity | 2.0 |
| Name | Percent |
|---|---|
| Ireland | 21.2 |
| Switzerland | 13.8 |
| France | 12.3 |
| Netherlands | 10.4 |
| United Kingdom | 8.7 |
| Germany | 8.6 |
| Italy | 6.7 |
| Denmark | 5.7 |
| Sweden | 3.3 |
| Other | 9.3 |
| Name | Percent |
|---|---|
| Healthcare | 25.0 |
| Financial Services | 15.4 |
| Industrial Goods | 13.6 |
| Consumer Goods | 13.3 |
| Technology | 12.3 |
| Energy | 8.6 |
| Real Estate | 4.8 |
| Industrial Services | 2.9 |
| Cash and Cash Equivalent | 2.2 |
| Other | 1.9 |
Growth of $10,000 (since inception)
For the period 05/14/2012 through 07/31/2026 tr.with $10,000 CAD investment, The value of the investment would be $26,233
Fund details (as of July 31, 2026)
| Top holdings | Percent (%) |
|---|---|
| ASML Holding NV | 7.3 |
| Eni SpA | 6.7 |
| Bank of Ireland Group PLC | 4.5 |
| Nestle SA Cl N | 4.2 |
| Roche Holding AG | 4.2 |
| Legrand SA | 3.9 |
| Steris PLC | 3.6 |
| Deutsche Boerse AG Cl N | 3.5 |
| GEA Group AG | 3.5 |
| Epiroc AB Cl B | 3.3 |
| Total allocation in top holdings | 44.7 |
| Portfolio characteristics | Value |
|---|---|
| Standard deviation | 9.27% |
| Dividend yield | 2.32% |
| Yield to maturity | - |
| Duration (years) | - |
| Coupon | - |
| Average credit rating | Not rated |
| Average market cap (million) | $173,010.0 |
Understanding returns
Annual compound returns (%)
| 1 MO | 3 MO | YTD | 1 YR |
|---|---|---|---|
| -0.43 | 3.74 | 7.42 | 15.40 |
| 3 YR | 5 YR | 10 YR | INCEPTION |
|---|---|---|---|
| 12.68 | 6.93 | 4.60 | 7.02 |
Calendar year returns (%)
| 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|
| 14.32 | 13.07 | 14.49 | -15.65 |
| 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|
| 10.52 | -10.69 | 10.23 | -7.26 |
Range of returns over five years (June 01, 2012 - July 31, 2026)
| Best return | Best period end date | Worst return | Worst period end date |
|---|---|---|---|
| 15.65% | May 2017 | -5.51% | Sep 2022 |
| Average return | % of periods with positive returns | Number of positive periods | Number of negative periods |
|---|---|---|---|
| 3.31% | 71 | 79 | 32 |
Q2 2026 Fund Commentary
Commentary and opinions are provided by Keyridge Asset Management Limited.
Market commentary
The conflict in the Middle East and its consequent impact on supply chains and interest rates was the most significant geopolitical and macroeconomic factor affecting European equities in the second quarter. With risk appetite troughing at the end of the first quarter, increased confidence in a resolution to the conflict drove positive market sentiment through the quarter and supported a strong rebound from earlier lows.
Performance
At the sector level, security selection contributed strongly to relative performance, with share price outperformance from DCC plc, ASML Holding NV and BNP Paribas SA. The Fund's underweight to U.K. equities also contributed as the U.K. was among the weakest markets in the quarter.
ASML Holding NV was the leading individual contributor. The company dominates the market for lithography machines, a vital process in the manufacture of advanced semiconductors for AI applications, and demand remains strong, which is feeding through into corporate results. William Demant Holding AS also contributed as demand for hearing aids improved following a period of slower post-pandemic growth, leading to stronger revenue growth reflected in share price performance. DCC plc contributed after two private equity firms, KKR and Energy Partners, returned to the table with a higher takeover offer, which is now reflected in the share price.
At the sector level, the Fund's overweight to health care detracted as the sector underperformed the benchmark, continuing a trend seen over several quarters. In the sub-advisor's view, companies in the health care sector continue to fit the investment philosophy of investing in quality companies at reasonable prices. An underweight to financials also detracted, as banks were among the strongest performing sub-sectors amid the potential for higher interest rates.
ENI SpA detracted the most from performance. The stock had performed strongly in the first quarter as the oil price rose amid the conflict in the Middle East, but underperformed in the second quarter as the oil price fell on the potential for a resolution. Coloplast AS also detracted; revenue growth was marginally weaker than expected, with China and the U.S. softer than anticipated, and cost inflation ran higher than expected, weighing on margins. CRH plc detracted as the potential for higher U.S. interest rates can be viewed as detrimental to demand for infrastructure and construction projects. CRH plc generates the majority of its profits in the U.S. and is therefore more exposed to U.S. rates.
Portfolio activity
The sub-advisor increased CaixaBank SA and BNP Paribas SA.
Outlook
In the sub-advisor's view, global economies continue to perform strongly, and corporate earnings are growing at healthy rates. Much of this growth is being driven by the information technology sector, but the sub-advisor believes growth is broadening across other sectors, which could benefit international equities.
Supply chain risk is an area the sub-advisor is monitoring closely. The use of oil is ubiquitous, either as a direct input into the manufacture of goods or indirectly as an energy source, and disruptions to oil supply could negatively affect many global sectors and Fund holdings. Inflation and the potential for higher interest rates is another area under close watch. Higher rates may benefit sectors like banks but could weigh on interest-rate-sensitive sectors such as utilities and real estate.